VSBC
Vitaspring Biomedical Co. Ltd.
$0.01
+0.00 (+0.00%)
At close · Jul 2
Going-concern doubt
— flagged Jun 17, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company’s minimal cash balance, recurring operating losses, and significant working capital deficit raise substantial doubt about its ability to continue as a going concern within one year after the financial statements are issued.”View the 10-Q filed Jun 17, 2026
Market Cap
$2.30M
Shares
207,030,030
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.01
Open$0.01
Day$0.01–0.01
52W$0.01–1.00
Avg vol 30d0
Short int50 · 0.0% float · 1000.0d
DataJan 2020–Jul 2026
Filing10-Q · Jun 17
Equibles Rating
blended score · not investment advice
Overall
Sell
Technical · trend & momentum
Sell
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−98% below
◦
Price vs 50-day avg
0% above
◦
RSI (14)
0 · oversold
+
MACD trend
positive
−
52-week position
0% · near low
Sentiment · smart money
Neutral
◦
Trend (MA cross)
50d $0 › 200d $1 — 200d above 50d
◦
Institutional flow
No 13F holder data
◦
Insider flow
No net insider activity over 90 days
◦
Short interest
0.00% of float · ▬ 0.0% MoM · 1000.0 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
No 13F holder history
Fundamentals
Weak
−
Free cash flow
$-2.7K
◦
Balance sheet
net cash $0
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
FQ2-27 quarter ends
~Jul 31, 2026
Est
filed Jun 17, 2026
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−98% below
Bearish
Price vs 50-day avg
0% above
Neutral
RSI (14)
0 · oversold
Neutral
MACD trend
positive
Bullish
52-week position
0% · near low
Bearish
Market signals — smart money & positioning
No clear signal
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
0.00% of float · ▬ 0.0% MoM · 1000.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
52-wk low $0
Now $0 · 0%
52-wk high $1
vs 200-day avg -98%
vs 50-day avg +0%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
VSBC
this stock
Vitaspring Biomedical Co. Ltd.
|
$2.30M | -98.9% | — | — | 0.0% |
|
AKTX
Akari Therapeutics Plc
|
$953.21B | -9.9% | — | — | 0.0% |
|
ONC
BeOne Medicines Ltd.
|
$470.30B | -2.0% | +22179.2% | 957.1 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$134.02B | +16.5% | +46.2% | 31.3 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.80B | -15.1% | +20.8% | 16.3 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| VSBC | +0.0% | +0.0% | -98.9% | +0.0% | -98.9% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | -1.4% | +1.3% | -106.9% | +0.3% | -108.1% |